CN101744892B - 首乌丹参滴丸中丹酚酸b含量测定方法 - Google Patents
首乌丹参滴丸中丹酚酸b含量测定方法 Download PDFInfo
- Publication number
- CN101744892B CN101744892B CN200810153630A CN200810153630A CN101744892B CN 101744892 B CN101744892 B CN 101744892B CN 200810153630 A CN200810153630 A CN 200810153630A CN 200810153630 A CN200810153630 A CN 200810153630A CN 101744892 B CN101744892 B CN 101744892B
- Authority
- CN
- China
- Prior art keywords
- polygoni multiflori
- salviae miltiorrhizae
- dripping pills
- radix salviae
- radix polygoni
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006187 pill Substances 0.000 title claims abstract description 56
- 239000002253 acid Substances 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims description 34
- 238000012360 testing method Methods 0.000 claims description 86
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- 239000000243 solution Substances 0.000 claims description 62
- 239000013558 reference substance Substances 0.000 claims description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 18
- 238000003556 assay Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 12
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 9
- 235000019253 formic acid Nutrition 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000003825 pressing Methods 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 240000007164 Salvia officinalis Species 0.000 claims description 5
- 235000005412 red sage Nutrition 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 4
- 229940116229 borneol Drugs 0.000 claims description 4
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000002137 ultrasound extraction Methods 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 241000830535 Ligustrum lucidum Species 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 238000003908 quality control method Methods 0.000 abstract description 8
- 239000000047 product Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000009849 vacuum degassing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007718 Stable Angina Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810153630A CN101744892B (zh) | 2008-11-28 | 2008-11-28 | 首乌丹参滴丸中丹酚酸b含量测定方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810153630A CN101744892B (zh) | 2008-11-28 | 2008-11-28 | 首乌丹参滴丸中丹酚酸b含量测定方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101744892A CN101744892A (zh) | 2010-06-23 |
CN101744892B true CN101744892B (zh) | 2012-09-05 |
Family
ID=42472907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810153630A Expired - Fee Related CN101744892B (zh) | 2008-11-28 | 2008-11-28 | 首乌丹参滴丸中丹酚酸b含量测定方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101744892B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129817A (zh) * | 2007-09-26 | 2008-02-27 | 王福春 | 一种治疗高血压的中药制剂及其制备方法 |
-
2008
- 2008-11-28 CN CN200810153630A patent/CN101744892B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101129817A (zh) * | 2007-09-26 | 2008-02-27 | 王福春 | 一种治疗高血压的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101744892A (zh) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104569170A (zh) | 一种银杏达莫注射制剂的检测方法 | |
CN101620207A (zh) | 一种参麦注射液中5-羟甲基糠醛的定量测定方法 | |
CN102445500B (zh) | 一种检测注射用益气复脉中的大分子物质的方法 | |
CN104345110A (zh) | 一种中药组合物制剂中七种成分的含量测定方法 | |
CN110780007B (zh) | 一种hplc法一测多评测定芒果止咳片6种成分含量的方法 | |
CN102445514A (zh) | 一种中药制剂金水宝胶囊的检测方法 | |
CN103048409A (zh) | 一种同时检测止咳宝片中四种有效成分含量的方法 | |
CN104007198B (zh) | 一种灵芝皇制剂hplc标准指纹图谱及其构建方法和应用 | |
CN104316613A (zh) | 一种疏风解毒胶囊指纹图谱的建立方法 | |
CN103575821A (zh) | 一种糖敏灵制剂中14种化学成分的检测方法 | |
CN110441407A (zh) | 一种泽术片质量控制方法 | |
CN105954432B (zh) | 一种银杏内酯b含量的检测方法 | |
CN103163243B (zh) | Hplc-dad法同时测定苦碟子注射液中五种有机酸类成分含量的方法 | |
CN102397331A (zh) | 一种高纯度银黄可溶性粉的制备及质量检测方法 | |
CN101744892B (zh) | 首乌丹参滴丸中丹酚酸b含量测定方法 | |
CN103389353A (zh) | 一种用超高效液相色谱法测定养血清脑颗粒中酚酸类成分含量的方法 | |
CN102706984A (zh) | 采用高效液相测定清肺消炎丸中盐酸麻黄碱含量的方法 | |
CN100445730C (zh) | 中药的柱分离洗脱液洗脱起始点或终点的快速监控方法 | |
CN102048906A (zh) | 鸡骨草胶囊的含量测定方法 | |
Chen et al. | Simultaneous determination of 5 phenolic acids in fried Fructus xanthii from different production sites and its dispensing granules by using ultra-pressure liquid chromatography | |
CN108414667A (zh) | 一种参桂益心颗粒质量标准的检测方法 | |
CN103575823A (zh) | 一种糖敏灵制剂中8种化学成分的检测方法 | |
CN101274036A (zh) | 苁黄补肾制剂质量标准的检测方法 | |
CN108195967A (zh) | 中药制剂中芍药苷和毛蕊异黄酮葡萄糖苷的含量测定方法 | |
CN101744891B (zh) | 首乌丹参滴丸中天然冰片含量测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Applicant after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Applicant before: TIANJIN TASLY PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN TIANSHILI PHARMACEUTICAL CO., LTD. TO: TASLY PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 Termination date: 20211128 |
|
CF01 | Termination of patent right due to non-payment of annual fee |